178 related articles for article (PubMed ID: 22912711)
1. Invasive pneumococcal disease in healthy adults: increase of empyema associated with the clonal-type Sweden(1)-ST306.
Grau I; Ardanuy C; Calatayud L; Rolo D; Domenech A; Liñares J; Pallares R
PLoS One; 2012; 7(8):e42595. PubMed ID: 22912711
[TBL] [Abstract][Full Text] [Related]
2. Smoking and alcohol abuse are the most preventable risk factors for invasive pneumonia and other pneumococcal infections.
Grau I; Ardanuy C; Calatayud L; Schulze MH; Liñares J; Pallares R
Int J Infect Dis; 2014 Aug; 25():59-64. PubMed ID: 24853638
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of invasive pneumococcal disease in older people in Spain (2007-2009): implications for future vaccination strategies.
Ardanuy C; Marimón JM; Calatayud L; Giménez M; Alonso M; Grau I; Pallarés R; Pérez-Trallero E; Liñares J
PLoS One; 2012; 7(8):e43619. PubMed ID: 22928005
[TBL] [Abstract][Full Text] [Related]
4. Comparison of invasive pneumococcal disease caused by serotype 19A and non-19A pneumococci in children: more empyema in serotype 19A invasive pneumococcal disease.
Lai CY; Huang LM; Lee PY; Lu CY; Shao PL; Chang LY
J Microbiol Immunol Infect; 2014 Feb; 47(1):23-7. PubMed ID: 23040234
[TBL] [Abstract][Full Text] [Related]
5. Serotypes and clones causing invasive pneumococcal disease before the use of new conjugate vaccines in Catalonia, Spain.
Muñoz-Almagro C; Ciruela P; Esteva C; Marco F; Navarro M; Bartolome R; Sauca G; Gallés C; Morta M; Ballester F; Raga X; Selva L;
J Infect; 2011 Aug; 63(2):151-62. PubMed ID: 21679725
[TBL] [Abstract][Full Text] [Related]
6. Invasive pneumococcal disease: Clinical outcomes and patient characteristics 2-6 years after introduction of 7-valent pneumococcal conjugate vaccine compared to the pre-vaccine period, the Netherlands.
Wagenvoort GH; Sanders EA; Vlaminckx BJ; Elberse KE; de Melker HE; van der Ende A; Knol MJ
Vaccine; 2016 Feb; 34(8):1077-85. PubMed ID: 26778420
[TBL] [Abstract][Full Text] [Related]
7. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF
Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490
[TBL] [Abstract][Full Text] [Related]
8. The spectrum of pneumococcal empyema in adults in the early 21st century.
Burgos J; Lujan M; Falcó V; Sánchez A; Puig M; Borrego A; Fontanals D; Planes AM; Pahissa A; Rello J
Clin Infect Dis; 2011 Aug; 53(3):254-61. PubMed ID: 21765073
[TBL] [Abstract][Full Text] [Related]
9. Streptococcus pneumoniae serotypes in Utah adults at the end of the PCV7 era.
Kendall BA; Dascomb KK; Mehta RR; Mason EO; Ampofo K; Pombo DJ; Pavia AT; Byington CL
Vaccine; 2011 Nov; 29(49):9123-6. PubMed ID: 22001280
[TBL] [Abstract][Full Text] [Related]
10. Serotype epidemiology of invasive pneumococcal disease in Swiss adults: a nationwide population-based study.
Meichtry J; Born R; Küffer M; Zwahlen M; Albrich WC; Brugger SD; Mühlemann K; Hilty M
Vaccine; 2014 Sep; 32(40):5185-91. PubMed ID: 25077419
[TBL] [Abstract][Full Text] [Related]
11. Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden.
Galanis I; Lindstrand A; Darenberg J; Browall S; Nannapaneni P; Sjöström K; Morfeldt E; Naucler P; Blennow M; Örtqvist Å; Henriques-Normark B
Eur Respir J; 2016 Apr; 47(4):1208-18. PubMed ID: 26797033
[TBL] [Abstract][Full Text] [Related]
12. Serotypes and genotypes of S. pneumoniae isolates from adult invasive disease in Spain: A 5-year prospective surveillance after pediatric PCV13 licensure. The ODIN study.
Fenoll A; Ardanuy C; Liñares J; Cercenado E; Marco F; Fleites A; Rodríguez-Mayo M; López-Hontangas JL; Palop B; Aller AI; Buendía B; Méndez C; Cifuentes I;
Vaccine; 2018 Dec; 36(52):7993-8000. PubMed ID: 30449634
[TBL] [Abstract][Full Text] [Related]
13. Early Streptococcus pneumoniae serotype changes in Utah adults after the introduction of PCV13 in children.
Kendall BA; Dascomb KK; Mehta RR; Stockmann C; Mason EO; Ampofo K; Pavia AT; Byington CL
Vaccine; 2016 Jan; 34(4):474-478. PubMed ID: 26706276
[TBL] [Abstract][Full Text] [Related]
14. Serotype and clonal distribution dynamics of invasive pneumococcal strains after PCV13 introduction (2011-2016): Surveillance data from 23 sites in Catalonia, Spain.
Ludwig G; Garcia-Garcia S; Lanaspa M; Ciruela P; Esteva C; Fernandez de Sevilla M; Diaz-Conradi A; Marti C; Motje M; Galles C; Morta M; Izquierdo C; Moraga-Llop F; Campins M; Salleras L; Jane M; Dominguez A; Garcia-Garcia JJ; Muñoz-Almagro C;
PLoS One; 2020; 15(2):e0228612. PubMed ID: 32027715
[TBL] [Abstract][Full Text] [Related]
15. Capsular serotypes and antimicrobial susceptibilities of Streptococcus pneumoniae causing invasive pneumococcal disease from 2009-2012 with an emphasis on serotype 19A in bacteraemic pneumonia and empyema and β-lactam resistance.
Lee MR; Chen CM; Chuang TY; Huang YT; Hsueh PR
Int J Antimicrob Agents; 2013 Nov; 42(5):395-402. PubMed ID: 24071028
[TBL] [Abstract][Full Text] [Related]
16. The changing epidemiology of invasive pneumococcal disease after PCV13 vaccination in a country with intermediate vaccination coverage.
Ciruela P; Izquierdo C; Broner S; Muñoz-Almagro C; Hernández S; Ardanuy C; Pallarés R; Domínguez A; Jané M;
Vaccine; 2018 Nov; 36(50):7744-7752. PubMed ID: 30473132
[TBL] [Abstract][Full Text] [Related]
17. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
Mokaddas E; Albert MJ
Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of invasive pneumococcal disease among adult patients in barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997-2007.
Ardanuy C; Tubau F; Pallares R; Calatayud L; Domínguez MA; Rolo D; Grau I; Martín R; Liñares J
Clin Infect Dis; 2009 Jan; 48(1):57-64. PubMed ID: 19035779
[TBL] [Abstract][Full Text] [Related]
19. Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014.
Nakano S; Fujisawa T; Ito Y; Chang B; Suga S; Noguchi T; Yamamoto M; Matsumura Y; Nagao M; Takakura S; Ohnishi M; Ihara T; Ichiyama S
Vaccine; 2016 Jan; 34(1):67-76. PubMed ID: 26602268
[TBL] [Abstract][Full Text] [Related]
20. Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine.
Muñoz-Almagro C; Jordan I; Gene A; Latorre C; Garcia-Garcia JJ; Pallares R
Clin Infect Dis; 2008 Jan; 46(2):174-82. PubMed ID: 18171247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
